The 150th American Neurological Association Annual Meeting (ANA 2025) was successfully held in Baltimore, USA, from September ...

Rising demand for mesenchymal stem cell (MSC)-based therapies, coupled with expanding applications in regenerative medicine, immunotherapy, and tissue engineering, is fueling strong growth in the ...

Ernexa’s recent update on operational excellence enables the company to allocate valuable resources where they are needed most: advancing ERNA-101 into clinical trials. The data that Dr. Andreeff is ...

PhaseV, a leader in AI/ML for clinical development, today announced a strategic partnership with Bioforum, a leading Contract ...

Metformin may lower the risk for long COVID at 1 year after SARS-CoV-2 infection in people with overweight or obesity, ...

Researchers have created BioCog, a self-administered digital cognitive test designed for primary care. The test assesses ...

In Europe, patients with shellfish-induced anaphylaxis differ from patients with fish-induced anaphylaxis in age and region, ...

Alzheimer's disease is the most common cause of dementia. As new disease-modifying treatments for Alzheimer's disease are now becoming available, both early and accurate diagnosis in a ...

Tirupati, is facing backlash from its alumni after it denied eligibility for the MSc medical postgraduates in the ...

Aligning artificial intelligence with patient needs, trial workflows, and employee experience enables adoption, builds trust, and ensures AI delivers measurable impact across clinical operations.

The Study Design and Data Analysis support group at USF’s College of Public Health (COPH), that’s who. Known as the SDDA, the ...

Periodontal disease remains one of the most prevalent oral health conditions worldwide, often managed through nonsurgical ...